These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23253254)

  • 21. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
    Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
    Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neoadjuvant chemotherapy as a treatment strategy for multiple bilobar liver metastases from colorectal carcinoma].
    Suzuki S; Sakaguchi T; Nakamura T; Nakamura S; Konno H
    Nihon Geka Gakkai Zasshi; 2006 May; 107(3):128-32. PubMed ID: 16734269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
    Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
    Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases.
    Hatwell C; Bretagnol F; Farges O; Belghiti J; Panis Y
    Colorectal Dis; 2013 Jan; 15(1):e21-8. PubMed ID: 23088162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.
    Brouquet A; Nordlinger B
    Scand J Gastroenterol; 2012 Mar; 47(3):286-95. PubMed ID: 22182353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.
    Ercolani G; Cucchetti A; Cescon M; Peri E; Brandi G; Del Gaudio M; Ravaioli M; Zanello M; Pinna AD
    Eur J Cancer; 2011 Oct; 47(15):2291-8. PubMed ID: 21652204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases.
    Eriksson S; Nilsson JH; Strandberg Holka P; Eberhard J; Keussen I; Sturesson C
    HPB (Oxford); 2017 Apr; 19(4):331-337. PubMed ID: 28089364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative or adjuvant therapy for resectable colorectal hepatic metastases.
    Petrelli NJ
    J Clin Oncol; 2008 Oct; 26(30):4862-3. PubMed ID: 18794535
    [No Abstract]   [Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy used for colorectal liver and lung metastasis resections.
    Redondo Capafons S; Planas Giner A; Garriga Biosca R; Pla Poblador R
    Farm Hosp; 2011; 35(5):255.e1-5. PubMed ID: 21439881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Eefsen RL; Engelholm L; Willemoe GL; Van den Eynden GG; Laerum OD; Christensen IJ; Rolff HC; Høyer-Hansen G; Osterlind K; Vainer B; Illemann M
    Int J Cancer; 2016 Apr; 138(7):1777-84. PubMed ID: 26510166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].
    Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.
    van der Pool AE; Lalmahomed ZS; Ozbay Y; de Wilt JH; Eggermont AM; Jzermans JN; Verhoef C
    Colorectal Dis; 2010 Oct; 12(10 Online):e229-35. PubMed ID: 19912286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical treatment of colorectal liver metastasis in the year 2000].
    Jakab F; Mersich T; Láng I
    Magy Seb; 2004 Feb; 57(1):3-11. PubMed ID: 15270518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.
    Viganò L; Langella S; Ferrero A; Russolillo N; Sperti E; Capussotti L
    Ann Surg Oncol; 2013 Mar; 20(3):938-45. PubMed ID: 23010733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High resectability of colorectal liver metastases with aggressive chemotherapy in the era of molecular target-based agents.
    Ochiai T; Ohta K; Iida M; Kumagai Y; Mitsunori Y; Aihara A; Noguchi N; Tanaka S; Arii S; Yamazaki S
    Hepatogastroenterology; 2013; 60(125):955-60. PubMed ID: 23803362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
    Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
    World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.